We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Lophius Biosciences Appoints Dr. Robert Phelps as Director Business Operations
News

Lophius Biosciences Appoints Dr. Robert Phelps as Director Business Operations

Lophius Biosciences Appoints Dr. Robert Phelps as Director Business Operations
News

Lophius Biosciences Appoints Dr. Robert Phelps as Director Business Operations

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Lophius Biosciences Appoints Dr. Robert Phelps as Director Business Operations"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Lophius Biosciences GmbH has announced that Dr. Robert Phelps has joined the Company as Director Business Operations.

Dr. Phelps has more than thirteen years successful international experiences in business development and licensing in the biotech and pharma industry.

Lastly, he has been Head of Business Development & Licensing at SuppreMol GmbH in Munich, where he was responsible for all business development and licensing activities relating to the company’s clinical drug development candidates.

Previous to that, he has held business development and licensing positions at various biotechnology and pharmaceutical companies.

Dr. Phelps received his PhD in biochemistry from the University of Frankfurt and the Paul-Ehrlich-Institut in Germany, held a research position as a post-doctoral fellow at the Medical University of South Carolina, Charleston (SC), USA, and holds the Certified Licensing Professional (CLP) credentials.

"With his longstanding experience in business development and licensing, we are happy that we were able to get Robert on board" said Prof. Ralf Wagner, Managing Director of Lophius Biosciences. “He is a valuable addition to our team and will be instrumental in supporting our efforts to exploit the excellent development and marketing opportunities for our T cell-based diagnostic systems such as T-Track® CMV."

"I am very happy to join Lophius," Dr. Phelps added. "The Company has been highly successful in transforming their T cell monitoring platform technologies into viable products enabling doctors to individually adjust prophylactic and immunosuppressive therapy e.g. during solid organ and bone marrow transplantation to the benefit of patients. I am extremely impressed by the potential of their platform technologies and their deep product pipeline.”

Advertisement